Endo International plc - Ordinary Shares (ENDP): Price and Financial Metrics
Endo International plc - Ordinary Shares (ENDP)
Today's Latest Price: $3.39 USD
Updated Aug 7 12:00am
Add ENDP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ENDP Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ENDP is -4.2 -- better than merely 3.04% of US stocks.
- ENDP's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 1.74% of US stocks.
- Over the past twelve months, ENDP has reported earnings growth of -736.44%, putting it ahead of just 2.77% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Endo International plc are SIX, SGMS, NCMI, TLGT, and EGLE.
- Visit ENDP's SEC page to see the company's official filings. To visit the company's web site, go to www.endo.com.
ENDP Stock Price Chart Technical Analysis Charts
ENDP Price/Volume Stats
| Current price | $3.39 | 52-week high | $7.10 |
| Prev. close | $3.54 | 52-week low | $1.97 |
| Day low | $3.34 | Volume | 4,621,900 |
| Day high | $3.55 | Avg. volume | 6,077,358 |
| 50-day MA | $3.57 | Dividend yield | N/A |
| 200-day MA | $4.35 | Market Cap | 778.70M |
Endo International plc - Ordinary Shares (ENDP) Company Bio
Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.
ENDP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $3.39 | $2.08 | -42% |
We started the process of determining a valid price forecast for Endo International plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Endo International plc ranked in the 35th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Endo International plc, consider:
- 9% of the company's capital comes from equity, which is greater than merely 3.46% of stocks in our cash flow based forecasting set.
- Endo International plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 17. This value is greater than 97.99% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -44% |
| 1% | -43% |
| 2% | -42% |
| 3% | -42% |
| 4% | -41% |
| 5% | -41% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ENDP, try GSK, STAA, USPH, ENTA, and MD.
Loading social stream, please wait...